Non-steroidal anti-inflammatory drugs in Indian rivers

Environmental Science and Pollution Research

Volumn 21, Issue 2, 2014, Pages 921-931

  Shanmugam, Govindaraj ^a   Sampath, Srimurali ^a   Selvaraj, Krishna Kumar ^a   Larsson, D G Joakim ^b   Ramaswamy, Babu Rajendran ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Acetylsalicylic acid; GC MS; India; NSAIDs; Pharmaceuticals; Risk assessment

Indexed keywords

DRUG; GAS CHROMATOGRAPHY; HEALTH RISK; MASS SPECTROMETRY; PUBLIC HEALTH; RISK ASSESSMENT; RIVER POLLUTION; SEWAGE TREATMENT; SURFACE WATER;

CAUVERY RIVER; INDIA; TAMIL NADU; THAMIRABARANI RIVER; VELLAR RIVER;

GINKGO BILOBA;

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CHEMISTRY; ENVIRONMENTAL MONITORING; HUMAN; INDIA; MASS FRAGMENTOGRAPHY; RIVER; SEWAGE; SOLID PHASE EXTRACTION; STATISTICS; WATER POLLUTANT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DICLOFENAC; ENVIRONMENTAL MONITORING; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IBUPROFEN; INDIA; KETOPROFEN; NAPROXEN; RIVERS; SEWAGE; SOLID PHASE EXTRACTION; WATER POLLUTANTS, CHEMICAL;

EID: 84891630360     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-013-1957-6     Document Type: Article

References (68)

1. American Public Health Association (1998) Standard methods for the examination of water and waste water. American Public Health Association, Washington.
2. Aydin E, Talinli I (2013) Analysis, occurrence and fate of commonly used pharmaceuticals and hormones in the Buyukcekmece watershed, Turkey. Chemosphere 90: 2004-2012.
3. Baranowska I, Kowalski B (2011) Using HPLC method with DAD detection for the simultaneous determination of 15 drugs in surface water and wastewater. Polish J Environ stud 20: 21-28.
4. Behera SK, Kim HW, Oh JE, Park HS (2011) Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci Total Environ 409: 435-4360.
5. Brown JN, Paxeus N, Forlin L, Larsson DGJ (2007) Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ Toxicol Pharmacol 2: 267-274.
6. Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee HB (2006) Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 25: 2163-2176.
7. Central Pollution Control Board (1993) Accessed from http://www. hppcb. gov. in/eiasorang/spec. pdf on 04/03/2013.
8. Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol Environ Saf 59: 309-315.
9. Cuklev F, Kristiansson K, Fick J, Asker N, Forlin L, Larsson DGJ (2011) Diclofenac in fish-blood plasma levels similar to human therapeutic levels affect global hepatic gene expression. Environ Toxicol Chem 30: 2126-2134.
10. Daneshvar A, Svanfelt J, Kronberg L, Weyhenmeyer G (2012) Neglected sources of pharmaceuticals in river water footprints of a Reggae festival. J Environ Monit 14: 596-603.
11. Desbrow C, Routledge EJ, Brighty GC, Sumpter JP, Waldock M (1998) Identification of estrogenic chemicals in STW effluents. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32: 1549-1558.
12. Diwan V, Tamhankar AJ, Aggarwal M, Sen S, Khandal RK, Lundborg CS (2009) Detection of antibiotics in hospital effluents in India. Current 97: 12-15.
13. European Agency for the Evaluation of Medicinal Products (2006) Committee for Medicinal Products for Human Use Guideline on the environmental risk assessment of medicinal products for human use. Ref EMEA/CRMP/SWP/4447/00. London, UK.
14. European Commission (2003) Technical Guidance Document in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Part II. Brussels, Belgium.
15. Farre ML, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barcelo D (2001) Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A 938: 187-197.
16. Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Giudice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23: 1344-1354.
17. Fick J, Soderstrom H, Lindberg RH, Phan C, Tysklind M, Larsson DGJ (2009) Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem 28: 2522-2527.
18. Fick J, Lindberg RH, Tysklind M, Larsson DGJ (2010) Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 58: 516-523.
19. Fram MS, Belitz K (2011) Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Sci Total Environ 409: 3409-3417.
20. Gros M, Petrovic M, Ginebreda A, Barcelo D (2010) Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36: 15-26.
21. Gunnarsson L, Jauhiainen A, Kristiansson E, Nerman O, Larsson DGJ (2008) Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 42: 5807-5813.
22. Helenkar A, Sebok A, Zaray G, Molnar Perl I, Vasanits-Zsigrai A (2010) The role of the acquisition methods in the analysis of the non-steroidal anti-inflammatory drugs in Danube river by gas chromatography-mass spectrometry. Talanta 82: 600-607.
23. Hernando MD, Mezcua M, Fernandez-Alba AR, Barcelo D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69: 334-342.
24. Ji K, Liu X, Lee S, Kang S, Kho Y, Giesy JP, Choi K (2013) Effects of non-steroidal anti-inflammatory drugs on hormones and genes of the hypothalamic-pituitary-gonad axis, and reproduction of zebrafish. J Hazard Mater 254-255: 242-251.
25. Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW (2007) Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci USA 104: 8897-8901.
26. Kamala K, Dinesh Kumar B (2006) Drug consumption pattern in urban and rural areas of India and their health implications. Proceedings of symposium on primary health care-new initiatives. Nutrition Foundation of India, New Delhi, pp 140-148.
27. Kim JW, Jang HS, Kim JG, Ishibashi H, Hirano M, Nasu K (2009) Occurrence of pharmaceutical and personal care products (PPCPs) in surface water from Mankyung River, South Korea. J Health Sci 55: 249-258.
28. Komori K, Suzuki Y, Minamiyama M, Harada A (2012) Occurrence of selected pharmaceuticals in river water in Japan and assessment of their environmental risk. Environ Monit Assess. doi: 10. 1007/s1066101228864.
29. Koreje K, Demeestere K, Wispelaere PD, Vergeynst L, Dewulf J, Langenhove HV (2012) From multiresidue screening to target analysis of pharmaceuticals in water: development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River basin, Kenya. Sci Tot Environ 437: 153-164.
30. Kosjek T, Heath E, Krbavcic A (2005) Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environ Inter 31: 679-685.
31. Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weijdegard B, Soderstrom H, Larsson DGJ (2011) Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS One 6: e17038.
32. Larsson DGJ, Adolfsson-Erici M, Parkkonen J, Pettersson M, Berg H, Olsson PE, Forlin L (1999) Ethinyloestradiol-an undesired fish contraceptive? Aquat Toxicol 45: 91-97.
33. Larsson DGJ, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148: 751-755.
34. Lin AY, Yu TH, Lateef SK (2009) Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J Hazard Mater 167: 1163-1169.
35. Lin AYC, Panchangam SC, Chen HY (2010) Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment. J Environ Monit 12: 261-270.
36. Mehinto AC, Hill EM, Tyler CR (2010) Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ Sci Technol 44: 2176-2182.
37. Memmert U, Peither A, Burri R, Weber K, Schmidt T, Sumpter JP (2013) Diclofenac: new data on chronic toxicity and bioconcentration in fish. Environ Toxicol Chem 32: 442-452.
38. Meyer B, Pailler JY, Guignard C, Hoffmann L, Krein A (2011) Concentrations of dissolved herbicides and pharmaceuticals in a small river in Luxembourg. Environ Monit Assess 180: 127-146.
39. Moldovan Z (2006) Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere 64: 1808-1817.
40. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Chaudhry MJI, Arshad M, Mahmood S, Ali A, Khan AA (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427: 630-633.
41. Patrolecco L, Ademollo N, Grenni P, Tolomei A, Barra Caracciolo A, Capri S (2013) Simultaneous determination of human pharmaceuticals in water samples by solid phase extraction and HPLC with UV-fluorescence detection. Microchem J 107: 165-171.
42. Paul AD, Chauhan CK (2005) Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting. Eur J Clin Pharmacol 60: 889-892.
43. Peng X, Yu Y, Tang C, Tan J, Huang Q, Wang Z (2008) Occurrence of steroid estrogens, endocrine-disrupting phenols, and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci Total Environ 397: 158-166.
44. Quinn B, Gagne F, Blaise C (2008) An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarians, Hydra attenuata. Sci Total Environ 389: 306-314.
45. Ramaswamy BR, Shanmugam G, Velu G, Rengarajan B, Larsson DGJ (2011) GC-MS analysis and ecotoxicological risk assessment of triclosan, carbamazepine and parabens in Indian Rivers. J Hazard Mater 186: 1586-1593.
46. Sanchez-Prado L, Garcia-Jares C, Llompart M (2010) Microwave-assisted extraction: application to the determination of emerging pollutants in solid samples. J Chromatogr A 1217: 2390-2414.
47. Santos JL, Aparicio I, Alonso E (2007) Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33: 596-601.
48. Santos JL, Aparicio I, Callejon M, Alonso E (2009) Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J Hazard Mater 164: 1509-1516.
49. Scheurell M, Franke S, Shah RM, Huhnerfuss H (2009) Occurrence of diclofenac and its metabolites in surface water and effluent samples from Karachi, Pakistan. Chemosphere 77: 870-876.
50. Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I. Histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68: 141-150.
51. Selke S, Scheurell M, Raza M, Hühnerfuss H (2010) Identification and enantioselective gas chromatographic mass-spectrometric separation of O-desmethylnaproxen, the main metabolite of the drug naproxen, as a new environmental contaminant. J Chromatogr A 1217: 419-423.
52. Shanmugam G, Ramaswamy BR, Radhakrishnan V, Tao H (2010) GC-MS method for the determination of paraben preservatives in the human breast cancerous tissue. Microchem J 96: 391-396.
53. Silva BFD, Jelic A, Lopez Serna R, Mozeto AA, Petrovic M, Barcelo D (2011) Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 85: 1331-1339.
54. Sim WJ, Lee JW, Oh JE (2010) Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ Pollut 158: 1938-1947.
55. Sousa MA, Goncalves C, Cunha E, Hajslova J, Alpendurada MF (2011) Cleanup strategies and advantages in the determination of several therapeutic classes of pharmaceuticals in wastewater samples by SPE-LC-MS/MS. Anal Bioanal Chem 399: 807-822.
56. Suarez S, Lema JM, Omil F (2010) Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res 44: 3214-3224.
57. Ternes T, Bonerz M, Schmidt M (2001) Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 938: 175-185.
58. Thorpe KL, Cummingsm RI, Tutchinson TH, Scholz M, Brighty G, Sumpter JP (2003) Relative potencies and combination effects of steroidal estrogens in fish. Environ Sci Technol 37: 1142-1149.
59. Togola A, Budzinski H (2007) Analytical development for analysis of pharmaceuticals in water samples by SPE and GC-MS. Anal Bioanal Chem 388: 627-635.
60. Triebskorn R, Casper H, Heyd A, Eikemper R, Kohler HR, Schwaiger J (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 68: 151-166.
61. Vulliet E, Cren-Olive C (2011) Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ Pollut 159: 292-2934.
62. Vystavna Y, Huneau F, Grynenko V, Vergeles Y, Celle-Jeanton H, Tapie N, Budzinski H, Coustumer PL (2012) Pharmaceuticals in rivers of two regions with contrasted socio-economic conditions: occurrence, accumulation, and comparison for Ukraine and France. Water Air Soil Pollut 223: 2111-2124.
63. Webb S, Ternes T, Gibert M, Olejniczak K (2003) Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 142: 157-167.
64. World Health Organization (2013) Accessed from http://www. whocc. no/atc_ddd_index/ on 04/03/2013.
65. Xu Y, Luo F, Pal A, Gin KY, Reinhard M (2011) Occurrence of emerging organic contaminants in a tropical urban catchment in Singapore. Chemosphere 83: 963-969.
66. Yoon Y, Ryu J, Oh J, Choi BG, Snyder SA (2010) Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci Total Environ 408: 636-643.
67. Zhang Y, Geissen SU, Gal C (2008) Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73: 1151-1161.
68. Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L, Yang XB, Stauber JL, Warne MS (2010) Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. Environ Toxicol Chem 29: 1377-1384.